Cargando…
Bi-directional drug-microbiome interactions of anti-diabetics
Type 2 diabetes (T2D) has become a global epidemic. Although several drugs are available to manage T2D, problems associated with person-to-person variability in drug efficacy and potential side-effects remain unresolved. Owing to the emerging role of the gut microbiome in obesity and T2D, the intera...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354569/ https://www.ncbi.nlm.nih.gov/pubmed/30553752 http://dx.doi.org/10.1016/j.ebiom.2018.11.046 |